Medical device maker Stryker to buy Vocera Communications for 2.97 Billion USD

Published On 2022-01-07 04:00 GMT   |   Update On 2022-01-07 04:00 GMT

New Delhi: Medical device maker Stryker Corp said on Thursday it had agreed to acquire digital care platform Vocera Communications Inc (VCRA.N) for about $2.97 billion.Vocera shares were up nearly 27% at $78.63 before the bell, just shy of the offer price of $79.25 per share.Also Read:IPC issues safety alerts on medical devices including Cranial Perforator, Orthopedic drillFounded in 2000,...

Login or Register to read the full article

New Delhi: Medical device maker Stryker Corp said on Thursday it had agreed to acquire digital care platform Vocera Communications Inc (VCRA.N) for about $2.97 billion.

Vocera shares were up nearly 27% at $78.63 before the bell, just shy of the offer price of $79.25 per share.

Also Read:IPC issues safety alerts on medical devices including Cranial Perforator, Orthopedic drill

Founded in 2000, Vocera caters to nearly 1,900 hospitals, allowing healthcare workers to communicate and collaborate with co-workers and engage with patients and their families.

The deal is expected to close in the first quarter of this year and is estimated to have a neutral impact on net earnings per diluted share in 2022, Stryker said.

Stryker shares were down nearly 1% at $270 in light premarket trading.

Also Read:Govt approves 8 more device manufacturers under PLI scheme for Medical Devices

Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News